L'Oreal USA 2025-05-21 Health serious FDA
Health · FDA · Recall #FDA-D-0419-2025
La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5%… Recall
Issued May 21, 2025 · L'Oreal USA
In May 2025, L'Oreal USA recalled the La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5%…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay Effaclar Duo Dual Action Acne Treatment lots.
What you should do
- 1 Stop using La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5%… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact L'Oreal USA to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- L'Oreal USA
- Category
- Health
- Recall date
- May 21, 2025
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-0419-2025
- Made in
- United States
- Issuing agency
- FDA
In context
- L'Oreal USA has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 691st Health recall we've logged in 2025.